#<p>Initial Rates were determined for 1 hour (Response; Arbitrary Fluorescence Units min<sup>−1</sup>).</p>*<p>The effect of DO on HA(Y308A) was determined by using co-expressed DM/DO complex.</p>¶<p>Determined in a separate experiment.</p
<p>(a) Competitive binding analysis of P1, P3 and P7 MTSL-Cys substituted HA peptide variants to DR1...
<p>(a) Real-time analysis of DR1/HAC stability as described in Results. (b) Real-time FP analysis of...
<p>(A) Amino-acid sequence and location of T*-1 and QNT-5 epitopes in T*. (B) Characterization of th...
<p>(A) Association of HA(Y308A) peptide to DR1 molecules in the presence of coinfected DM/DO complex...
<p>(A) Association (left) and dissociation (right) of HA(306–318) peptide to DR1 molecules with no a...
<p>(A) Association (left) and dissociation (right) of CII(259–273) peptide to DR1 molecules with no ...
<p>Mags.DO5 purified DM/DO was immobilized on anti-His antibody coupled chip surface to a level of 2...
<p>(a) Association rate of peptides to DR1 in the presence of DM was measured as described in Result...
<p>(a) Dissociation rate of peptides from HLA-DR1 in the presence of DM was measured as described in...
<p>(A, B) DR1β mutants H81A, V85S and V85D and DRα mutant S53A were compared with wild type DR1 comp...
<p>The ability of Y1MxN photocleavable peptide to bind DR1 was measured in a competition binding ass...
<p>(A–C) SPR binding curves for DR1 molecules covalently linked to the P6 position of peptides indic...
<p>(A) SPR sensograms of constitutively receptive DR1βG86Y (4µM) binding to DO. Ni-NTA purified DO w...
<p>(a) DM-mediated and intrinsic dissociation of HAD from DR1 was measured as described in <a href="...
Major histocompatibility complex (MHC) class I molecules bind peptides in the endoplasmic reticulum ...
<p>(a) Competitive binding analysis of P1, P3 and P7 MTSL-Cys substituted HA peptide variants to DR1...
<p>(a) Real-time analysis of DR1/HAC stability as described in Results. (b) Real-time FP analysis of...
<p>(A) Amino-acid sequence and location of T*-1 and QNT-5 epitopes in T*. (B) Characterization of th...
<p>(A) Association of HA(Y308A) peptide to DR1 molecules in the presence of coinfected DM/DO complex...
<p>(A) Association (left) and dissociation (right) of HA(306–318) peptide to DR1 molecules with no a...
<p>(A) Association (left) and dissociation (right) of CII(259–273) peptide to DR1 molecules with no ...
<p>Mags.DO5 purified DM/DO was immobilized on anti-His antibody coupled chip surface to a level of 2...
<p>(a) Association rate of peptides to DR1 in the presence of DM was measured as described in Result...
<p>(a) Dissociation rate of peptides from HLA-DR1 in the presence of DM was measured as described in...
<p>(A, B) DR1β mutants H81A, V85S and V85D and DRα mutant S53A were compared with wild type DR1 comp...
<p>The ability of Y1MxN photocleavable peptide to bind DR1 was measured in a competition binding ass...
<p>(A–C) SPR binding curves for DR1 molecules covalently linked to the P6 position of peptides indic...
<p>(A) SPR sensograms of constitutively receptive DR1βG86Y (4µM) binding to DO. Ni-NTA purified DO w...
<p>(a) DM-mediated and intrinsic dissociation of HAD from DR1 was measured as described in <a href="...
Major histocompatibility complex (MHC) class I molecules bind peptides in the endoplasmic reticulum ...
<p>(a) Competitive binding analysis of P1, P3 and P7 MTSL-Cys substituted HA peptide variants to DR1...
<p>(a) Real-time analysis of DR1/HAC stability as described in Results. (b) Real-time FP analysis of...
<p>(A) Amino-acid sequence and location of T*-1 and QNT-5 epitopes in T*. (B) Characterization of th...
DOI
Add to ORKG